These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
678 related items for PubMed ID: 19555243
21. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets. Khairuzzaman A, Ahmed SU, Savva M, Patel NK. Int J Pharm; 2006 Aug 02; 318(1-2):15-21. PubMed ID: 16621361 [Abstract] [Full Text] [Related]
22. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Hayashi T, Kanbe H, Okada M, Suzuki M, Ikeda Y, Onuki Y, Kaneko T, Sonobe T. Int J Pharm; 2005 Nov 04; 304(1-2):91-101. PubMed ID: 16154302 [Abstract] [Full Text] [Related]
23. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Trapani A, Laquintana V, Denora N, Lopedota A, Cutrignelli A, Franco M, Trapani G, Liso G. Eur J Pharm Sci; 2007 Jan 04; 30(1):64-74. PubMed ID: 17118631 [Abstract] [Full Text] [Related]
24. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin. Chowdary KP, Kamalakara RG. Pharmazie; 2003 Oct 04; 58(10):721-4. PubMed ID: 14609284 [Abstract] [Full Text] [Related]
25. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose. Chen L, Wang F. Pharmazie; 2013 Oct 04; 68(10):796-9. PubMed ID: 24273882 [Abstract] [Full Text] [Related]
26. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME. Drug Dev Ind Pharm; 2013 Nov 04; 39(11):1651-62. PubMed ID: 23094867 [Abstract] [Full Text] [Related]
27. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ. Eur J Pharm Biopharm; 2007 Jun 04; 66(3):413-21. PubMed ID: 17240129 [Abstract] [Full Text] [Related]
28. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets. Tajarobi F, Abrahmsén-Alami S, Carlsson AS, Larsson A. Eur J Pharm Sci; 2009 May 12; 37(2):89-97. PubMed ID: 19429415 [Abstract] [Full Text] [Related]
29. Evaluation of khaya gum as a directly compressible matrix system for controlled release. Odeku OA, Fell JT. J Pharm Pharmacol; 2004 Nov 12; 56(11):1365-70. PubMed ID: 15525442 [Abstract] [Full Text] [Related]
30. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads. Smith JS, Macrae RJ, Snowden MJ. Eur J Pharm Biopharm; 2005 May 12; 60(1):73-80. PubMed ID: 15848059 [Abstract] [Full Text] [Related]
31. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity. Viridén A, Abrahmsén-Alami S, Wittgren B, Larsson A. Eur J Pharm Biopharm; 2011 Aug 12; 78(3):470-9. PubMed ID: 21316446 [Abstract] [Full Text] [Related]
35. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release. Nokhodchi A, Aliakbar R, Desai S, Javadzadeh Y. Colloids Surf B Biointerfaces; 2010 Aug 01; 79(1):262-9. PubMed ID: 20451361 [Abstract] [Full Text] [Related]